Atenolol and Chlorthalidone NDC 70954-390

NDC codes

FDA NDC Directory

Product NDC (as listed)70954-390Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70954-0390Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70954-390-10	70954039010	100 TABLET in 1 BOTTLE (70954-390-10)Marketed from Oct 25, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Atenolol and Chlorthalidone
Generic name (nonproprietary): atenolol and chlorthalidone
Active ingredients: Atenolol — 50 mg/1Chlorthalidone — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: ANI Pharmaceuticals, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215560
Marketing start: Oct 25, 2021
Listing expires: Dec 31, 2026
Other FDA classes: Adrenergic beta-Antagonists (Mechanism)Increased Diuresis (Physiologic effect)
Identifiers: Product ID 70954-390_1dade55e-a8a5-4e38-8ad7-9caa4ceb0cd0SPL ID 1dade55e-a8a5-4e38-8ad7-9caa4ceb0cd0SPL set ID 33690cc7-fffc-4620-888d-7f6453fe58c1RxCUI 197382, 197383UNII 50VV3VW0TI, Q0MQD1073QUPC 0370954390107, 0370954391104
Pharmacologic class: Thiazide-like Diuretic; beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470954039010 followed by a unit qualifier and the quantity

Package 70954-0390-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 14, 2024.

Indications (excerpt from the label)

INDICATIONS & USAGE Atenolol and Chlorthalidone Tablets, USP are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including atenolol and chlorthalidone. Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more th…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215560

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215560
Product	Strength	Form · route	Labeler	Product NDC
Atenolol And Chlorthalidoneatenolol and chlorthalidone tablet	Chlorthalidone 25 mg/1; Atenolol 50 mg/1	TabletOral	MARLEX PHARMACEUTICALS, INC	10135-733
Atenolol And Chlorthalidoneatenolol and chlorthalidone tablet	Atenolol 100 mg/1; Chlorthalidone 25 mg/1	TabletOral	MARLEX PHARMACEUTICALS, INC	10135-734
Atenolol and Chlorthalidone	Atenolol 100 mg/1; Chlorthalidone 25 mg/1	TabletOral	ANI Pharmaceuticals, Inc.	70954-391